The Adenosine Monophosphate Activated Protein Kinase pipeline drugs market research report outlays comprehensive information on the Adenosine Monophosphate Activated Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Adenosine Monophosphate Activated Protein Kinase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
Smarter leaders trust GlobalData
The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Oncology, and Gastrointestinal which include the indications Type 2 Diabetes, Obesity, Congestive Heart Failure (Heart Failure), Diastolic Heart Failure (HFpEF), Unspecified Cancer, Breast Cancer, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Liver Fibrosis. It also reviews key players involved in Adenosine Monophosphate Activated Protein Kinase targeted therapeutics development with respective active and dormant or discontinued products.
The Adenosine Monophosphate Activated Protein Kinase pipeline targets constitutes close to 63 molecules. Out of which, approximately 55 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, IND/ CTA Filed, Preclinical, and Discovery stages are 2, 8, 7, 10, 5, 15, and 7 respectively. Similarly, the universities portfolio in Phase I, Preclinical, and Discovery comprises 1, 6, and 1 molecule.
Adenosine Monophosphate Activated Protein Kinase overview
Adenosine monophosphate-activated protein kinase (AMPK) is a crucial cellular enzyme that acts as a metabolic “fuel gauge” by monitoring cellular energy levels. It is a heterotrimeric protein composed of three subunits: α, β, and γ. The α subunit is the catalytic subunit, responsible for the enzyme’s activity, while the β and γ subunits serve as regulatory subunits. AMPK plays a critical role in maintaining cellular energy homeostasis by regulating various metabolic processes, including glucose and fatty acid uptake, mitochondrial biogenesis, and autophagy.
For a complete picture of Adenosine Monophosphate Activated Protein Kinase’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third-party sources.
Drug profiles featured in the report undergo periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
